For: | Lyra A, Rinttilä T, Nikkilä J, Krogius-Kurikka L, Kajander K, Malinen E, Mättö J, Mäkelä L, Palva A. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification. World J Gastroenterol 2009; 15(47): 5936-5945 [PMID: 20014457 DOI: 10.3748/wjg.15.5936] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i47/5936.htm |
Number | Citing Articles |
1 |
Ian B. Jeffery, Eamonn M. M. Quigley, Lena Öhman, Magnus Simrén, Paul W. O'Toole. The microbiota link to irritable bowel syndrome. Gut Microbes 2012; 3(6): 572 doi: 10.4161/gmic.21772
|
2 |
Chih-Min Chiu, Feng-Mao Lin, Tzu-Hao Chang, Wei-Chih Huang, Chao Liang, Ting Yang, Wei-Yun Wu, Tzu-Ling Yang, Shun-Long Weng, Hsien-Da Huang. Clinical detection of human probiotics and human pathogenic bacteria by using a novel high-throughput platform based on next generation sequencing. Journal of Clinical Bioinformatics 2014; 4(1): 1 doi: 10.1186/2043-9113-4-1
|
3 |
Lisa Vork, John Penders, Jonna Jalanka, Svetlana Bojic, Sander M. J. van Kuijk, Anne Salonen, Willem M. de Vos, Mirjana Rajilic-Stojanovic, Zsa Zsa R. M. Weerts, Ad A. M. Masclee, Marta Pozuelo, Chaysavanh Manichanh, Daisy M. A. E. Jonkers. Does Day-to-Day Variability in Stool Consistency Link to the Fecal Microbiota Composition?. Frontiers in Cellular and Infection Microbiology 2021; 11 doi: 10.3389/fcimb.2021.639667
|
4 |
Rachel D. Moloney, Anthony C. Johnson, Siobhain M. O'Mahony, Timothy G. Dinan, Beverley Greenwood‐Van Meerveld, John F. Cryan. Stress and the Microbiota–Gut–Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome. CNS Neuroscience & Therapeutics 2016; 22(2): 102 doi: 10.1111/cns.12490
|
5 |
Sean M.P. Bennet, Lena Ohman, Magnus Simren. Gut Microbiota as Potential Orchestrators of Irritable Bowel Syndrome. Gut and Liver 2015; 9(3) doi: 10.5009/gnl14344
|
6 |
Giovanni Barbara, Cesare Cremon, Giovanni Carini, Lara Bellacosa, Lisa Zecchi, Roberto De Giorgio, Roberto Corinaldesi, Vincenzo Stanghellini. The Immune System in Irritable Bowel Syndrome. Journal of Neurogastroenterology and Motility 2011; 17(4): 349 doi: 10.5056/jnm.2011.17.4.349
|
7 |
Reza Rastmanesh. High polyphenol, low probiotic diet for weight loss because of intestinal microbiota interaction. Chemico-Biological Interactions 2011; 189(1-2): 1 doi: 10.1016/j.cbi.2010.10.002
|
8 |
Giorgio Gargari, Valentina Taverniti, Claudio Gardana, Cesare Cremon, Filippo Canducci, Isabella Pagano, Maria Raffaella Barbaro, Lara Bellacosa, Anna Maria Castellazzi, Chiara Valsecchi, Sara Carlotta Tagliacarne, Massimo Bellini, Lorenzo Bertani, Dario Gambaccini, Santino Marchi, Michele Cicala, Bastianello Germanà, Elisabetta Dal Pont, Maurizio Vecchi, Cristina Ogliari, Walter Fiore, Vincenzo Stanghellini, Giovanni Barbara, Simone Guglielmetti. Fecal Clostridiales distribution and short‐chain fatty acids reflect bowel habits in irritable bowel syndrome. Environmental Microbiology 2018; 20(9): 3201 doi: 10.1111/1462-2920.14271
|
9 |
Yuan-Cheng Chen, Jonathan Greenbaum, Hui Shen, Hong-Wen Deng. Association Between Gut Microbiota and Bone Health: Potential Mechanisms and Prospective. The Journal of Clinical Endocrinology & Metabolism 2017; 102(10): 3635 doi: 10.1210/jc.2017-00513
|
10 |
Duane Charbonneau, Roger D. Gibb, Eamonn M.M. Quigley. Fecal excretion of Bifidobacterium infantis 35624 and changes in fecal microbiota after eight weeks of oral supplementation with encapsulated probiotic. Gut Microbes 2013; 4(3): 201 doi: 10.4161/gmic.24196
|
11 |
Yeon Bee Kim, Tae Woong Whon, Joon Yong Kim, Juseok Kim, Yujin Kim, Se Hee Lee, Seong-Eun Park, Eun-Ju Kim, Hong-Seok Son, Seong Woon Roh. In-depth metataxonomic investigation reveals low richness, high intervariability, and diverse phylotype candidates of archaea in the human urogenital tract. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-38710-9
|
12 |
Francesco Miragoli, Sara Federici, Susanna Ferrari, Andrea Minuti, Annalisa Rebecchi, Eugenia Bruzzese, Vittoria Buccigrossi, Alfredo Guarino, Maria Luisa Callegari, Julian Marchesi. Impact of cystic fibrosis disease on archaea and bacteria composition of gut microbiota. FEMS Microbiology Ecology 2017; 93(2): fiw230 doi: 10.1093/femsec/fiw230
|
13 |
Laura Rigsbee, Richard Agans, Vijay Shankar, Harshavardhan Kenche, Harry J Khamis, Sonia Michail, Oleg Paliy. Quantitative Profiling of Gut Microbiota of Children With Diarrhea-Predominant Irritable Bowel Syndrome. American Journal of Gastroenterology 2012; 107(11): 1740 doi: 10.1038/ajg.2012.287
|
14 |
Ketrija Touw, Daina L. Ringus, Nathaniel Hubert, Yunwei Wang, Vanessa A. Leone, Anuradha Nadimpalli, Betty R. Theriault, Yong E. Huang, Johnathan D. Tune, Paul B. Herring, Gianrico Farrugia, Purna C. Kashyap, Dionysios A. Antonopoulos, Eugene B. Chang. Mutual reinforcement of pathophysiological host‐microbe interactions in intestinal stasis models. Physiological Reports 2017; 5(6) doi: 10.14814/phy2.13182
|
15 |
Sophie Fowler, Emily C. Hoedt, Nicholas J. Talley, Simon Keely, Grace L. Burns. Circadian Rhythms and Melatonin Metabolism in Patients With Disorders of Gut-Brain Interactions. Frontiers in Neuroscience 2022; 16 doi: 10.3389/fnins.2022.825246
|
16 |
Nozomi Matsuura, Masaya Kanayama, Yuta Watanabe, Hirokazu Yamada, Loukia Lili, Akira Torii. Effect of Personalized Prebiotic and Probiotic Supplements on the Symptoms of Irritable Bowel Syndrome: An Open-Label, Single-Arm, Multicenter Clinical Trial. Nutrients 2024; 16(19): 3333 doi: 10.3390/nu16193333
|
17 |
Natalia Zeber-Lubecka, Maria Kulecka, Filip Ambrozkiewicz, Agnieszka Paziewska, Krzysztof Goryca, Jakub Karczmarski, Tymon Rubel, Wojciech Wojtowicz, Piotr Mlynarz, Lukasz Marczak, Roman Tomecki, Michal Mikula, Jerzy Ostrowski. Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome. Gut Microbes 2016; 7(5): 397 doi: 10.1080/19490976.2016.1215805
|
18 |
Hui Zhu, Dong Zeng, Qiang Wang, Ning Wang, Bo Zeng, Lili Niu, Xueqin Ni. Diarrhea-Associated Intestinal Microbiota in Captive Sichuan Golden Snub-Nosed Monkeys (<i>Rhinopithecus roxellana</i>). Microbes and Environments 2018; 33(3): 249 doi: 10.1264/jsme2.ME17163
|
19 |
Cristina Iribarren, Otto Savolainen, Maria Sapnara, Hans Törnblom, Magnus Simrén, Maria K. Magnusson, Lena Öhman. Temporal stability of fecal metabolomic profiles in irritable bowel syndrome. Neurogastroenterology & Motility 2024; 36(3) doi: 10.1111/nmo.14741
|
20 |
Manon Defaye, Sandie Gervason, Christophe Altier, Jean-Yves Berthon, Denis Ardid, Edith Filaire, Frédéric Antonio Carvalho. Microbiota: a novel regulator of pain. Journal of Neural Transmission 2020; 127(4): 445 doi: 10.1007/s00702-019-02083-z
|
21 |
A. J. Park, J. Collins, P. A. Blennerhassett, J. E. Ghia, E. F. Verdu, P. Bercik, S. M. Collins. Altered colonic function and microbiota profile in a mouse model of chronic depression. Neurogastroenterology & Motility 2013; 25(9): 733 doi: 10.1111/nmo.12153
|
22 |
Leonilde Bonfrate, Jan Tack, Ignazio Grattagliano, Rosario Cuomo, Piero Portincasa. Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options. Scandinavian Journal of Gastroenterology 2013; 48(9): 995 doi: 10.3109/00365521.2013.799220
|
23 |
Uday C. Ghoshal, Ratnakar Shukla, Ujjala Ghoshal, Kok-Ann Gwee, Siew C. Ng, Eamonn M. M. Quigley. The Gut Microbiota and Irritable Bowel Syndrome: Friend or Foe?. International Journal of Inflammation 2012; 2012: 1 doi: 10.1155/2012/151085
|
24 |
Simon Keely, Caleb J. Kelly, Thomas Weissmueller, Adrianne Burgess, Brandie D. Wagner, Charles E. Robertson, J. Kirk Harris, Sean P. Colgan. Activated fluid transport regulates bacterial-epithelial interactions and significantly shifts the murine colonic microbiome. Gut Microbes 2012; 3(3): 250 doi: 10.4161/gmic.20529
|
25 |
Ioana-Miruna Balmus, Ovidiu-Dumitru Ilie, Alin Ciobica, Roxana-Oana Cojocariu, Carol Stanciu, Anca Trifan, Mirela Cimpeanu, Cristian Cimpeanu, Lucian Gorgan. Irritable Bowel Syndrome between Molecular Approach and Clinical Expertise—Searching for Gap Fillers in the Oxidative Stress Way of Thinking. Medicina 2020; 56(1): 38 doi: 10.3390/medicina56010038
|
26 |
Ian B. Jeffery, Marcus J. Claesson, Paul O’Toole. Encyclopedia of Metagenomics. 2012; : 1 doi: 10.1007/978-1-4614-6418-1_96-1
|
27 |
Dandan Ma, Miao Yu, Minhong Zhang, Jinghai Feng. Research Note: The effect of photoperiod on the NLRP3 inflammasome and gut microbiota in broiler chickens. Poultry Science 2024; 103(4): 103507 doi: 10.1016/j.psj.2024.103507
|
28 |
Frances Widjaja, Ivonne M. C. M. Rietjens. From-Toilet-to-Freezer: A Review on Requirements for an Automatic Protocol to Collect and Store Human Fecal Samples for Research Purposes. Biomedicines 2023; 11(10): 2658 doi: 10.3390/biomedicines11102658
|
29 |
C. Chassard, M. Dapoigny, K. P. Scott, L. Crouzet, C. Del'homme, P. Marquet, J. C. Martin, G. Pickering, D. Ardid, A. Eschalier, C. Dubray, H. J. Flint, A. Bernalier‐Donadille. Functional dysbiosis within the gut microbiota of patients with constipated‐irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 2012; 35(7): 828 doi: 10.1111/j.1365-2036.2012.05007.x
|
30 |
Hai-Ning Liu, Hao Wu, Yu-Zhuo Chen, Yan-Jie Chen, Xi-Zhong Shen, Tao-Tao Liu. Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis. Digestive and Liver Disease 2017; 49(4): 331 doi: 10.1016/j.dld.2017.01.142
|
31 |
Piero Portincasa, Leonilde Bonfrate, Ornella de Bari, Anthony Lembo, Sarah Ballou. Irritable bowel syndrome and diet. Gastroenterology Report 2017; 5(1): 11 doi: 10.1093/gastro/gow047
|
32 |
Shreyas V. Kumbhare, Patricia A. Francis-Lyon, Dashyanng Kachru, Tejaswini Uday, Carmel Irudayanathan, Karthik M. Muthukumar, Roshni R. Ricchetti, Simitha Singh-Rambiritch, Juan Ugalde, Parambir S. Dulai, Daniel E. Almonacid, Ranjan Sinha. Digital Therapeutics Care Utilizing Genetic and Gut Microbiome Signals for the Management of Functional Gastrointestinal Disorders: Results From a Preliminary Retrospective Study. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.826916
|
33 |
Anton Emmanuel, Darryl Landis, Mark Peucker, A Pali S Hungin. Faecal biomarker patterns in patients with symptoms of irritable bowel syndrome. Frontline Gastroenterology 2016; 7(4): 275 doi: 10.1136/flgastro-2015-100651
|
34 |
Ulla Hynönen, Erwin G. Zoetendal, Anna-Maija K. Virtala, Sudarshan Shetty, Shah Hasan, Miia Jakava-Viljanen, Willem M. de Vos, Airi Palva. Molecular ecology of the yet uncultured bacterial Ct85-cluster in the mammalian gut. Anaerobe 2020; 62: 102104 doi: 10.1016/j.anaerobe.2019.102104
|
35 |
Yogesh Bhattarai, David A. Muniz Pedrogo, Purna C. Kashyap. Irritable bowel syndrome: a gut microbiota-related disorder?. American Journal of Physiology-Gastrointestinal and Liver Physiology 2017; 312(1): G52 doi: 10.1152/ajpgi.00338.2016
|
36 |
W.-T. Fan, C. Ding, N.-N. Xu, S. Zong, P. Ma, B. Gu. Close association between intestinal microbiota and irritable bowel syndrome. European Journal of Clinical Microbiology & Infectious Diseases 2017; 36(12): 2303 doi: 10.1007/s10096-017-3060-2
|
37 |
Ragnar K. Breckan, Anne Mette Asfeldt, Bjørn Straume, Jon Florholmen, Eyvind J. Paulssen. Prevalence, comorbidity, and risk factors for functional bowel symptoms: a population-based survey in Northern Norway. Scandinavian Journal of Gastroenterology 2012; 47(11): 1274 doi: 10.3109/00365521.2012.688215
|
38 |
Silvia Arboleya, Claire Watkins, Catherine Stanton, R. Paul Ross. Gut Bifidobacteria Populations in Human Health and Aging. Frontiers in Microbiology 2016; 7 doi: 10.3389/fmicb.2016.01204
|
39 |
Ujjala Ghoshal, Ratnakar Shukla, Deepakshi Srivastava, Uday C Ghoshal. Irritable Bowel Syndrome, Particularly the Constipation-Predominant Form, Involves an Increase inMethanobrevibacter smithii, Which Is Associated with Higher Methane Production. Gut and Liver 2016; 10(6): 932 doi: 10.5009/gnl15588
|
40 |
M. de Greck, P. Layer, V. Andresen. Schmerztherapie beim Reizdarmsyndrom. Der Schmerz 2014; 28(3): 289 doi: 10.1007/s00482-014-1406-6
|
41 |
Hamed Ebrahimzadeh Leylabadlo, Fatemah Sadeghpour Heravi, Elghar Soltani, Amin Abbasi, Hossein Samadi Kafil, Mahdi Parsaei, Sarvin Sanaie, Zainab Ahmadian, Reza Ghotaslou. The role of gut microbiota in the treatment of irritable bowel syndrome. Reviews in Medical Microbiology 2022; 33(1): e89 doi: 10.1097/MRM.0000000000000284
|
42 |
Anne Salonen, Willem M. de Vos, Airi Palva. Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. Microbiology 2010; 156(11): 3205 doi: 10.1099/mic.0.043257-0
|
43 |
Eamonn M.M. Quigley. Commensal bacteria. Current Opinion in Clinical Nutrition and Metabolic Care 2011; 14(5): 497 doi: 10.1097/MCO.0b013e328348c033
|
44 |
Chih-Min Chiu, Wei-Chih Huang, Shun-Long Weng, Han-Chi Tseng, Chao Liang, Wei-Chi Wang, Ting Yang, Tzu-Ling Yang, Chen-Tsung Weng, Tzu-Hao Chang, Hsien-Da Huang. Systematic Analysis of the Association between Gut Flora and Obesity through High-Throughput Sequencing and Bioinformatics Approaches. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/906168
|
45 |
Marta Pozuelo, Suchita Panda, Alba Santiago, Sara Mendez, Anna Accarino, Javier Santos, Francisco Guarner, Fernando Azpiroz, Chaysavanh Manichanh. Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome. Scientific Reports 2015; 5(1) doi: 10.1038/srep12693
|
46 |
Ian M. Carroll, Tamar Ringel-Kulka, Temitope O. Keku, Young-Hyo Chang, Christopher D. Packey, R. Balfour Sartor, Yehuda Ringel. Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. American Journal of Physiology-Gastrointestinal and Liver Physiology 2011; 301(5): G799 doi: 10.1152/ajpgi.00154.2011
|
47 |
Rachel D. Moloney, Siobhain M. O’Mahony, Timothy G. Dinan, John F. Cryan. Stress-Induced Visceral Pain: Toward Animal Models of Irritable-Bowel Syndrome and Associated Comorbidities. Frontiers in Psychiatry 2015; 6 doi: 10.3389/fpsyt.2015.00015
|
48 |
Julius Goepp, Elizabeth Fowler, Teresa Mcbride, Darryl Landis. Frequency of Abnormal Fecal Biomarkers in Irritable Bowel Syndrome. Global Advances in Health and Medicine 2014; 3(3): 9 doi: 10.7453/gahmj.2013.099
|
49 |
D. M. Pinn, O. C. Aroniadis, L. J. Brandt. Is fecal microbiota transplantation (FMT) an effective treatment for patients with functional gastrointestinal disorders (FGID)?. Neurogastroenterology & Motility 2015; 27(1): 19 doi: 10.1111/nmo.12479
|
50 |
William A. Walters, Faviola Reyes, Giselle M. Soto, Nathanael D. Reynolds, Jamie A. Fraser, Ricardo Aviles, David R. Tribble, Adam P. Irvin, Nancy Kelley-Loughnane, Ramiro L. Gutierrez, Mark S. Riddle, Ruth E. Ley, Michael S. Goodson, Mark P. Simons, Brenda A. Wilson. Epidemiology and associated microbiota changes in deployed military personnel at high risk of traveler's diarrhea. PLOS ONE 2020; 15(8): e0236703 doi: 10.1371/journal.pone.0236703
|
51 |
Ying Zhou, Minhong Zhang, Xin Zhao, Jinghai Feng. Ammonia exposure induced intestinal inflammation injury mediated by intestinal microbiota in broiler chickens via TLR4/TNF-α signaling pathway. Ecotoxicology and Environmental Safety 2021; 226: 112832 doi: 10.1016/j.ecoenv.2021.112832
|
52 |
Jacoline Gerritsen, Hauke Smidt, Ger T. Rijkers, Willem M. de Vos. Intestinal microbiota in human health and disease: the impact of probiotics. Genes & Nutrition 2011; 6(3): 209 doi: 10.1007/s12263-011-0229-7
|
53 |
Mak Adam Daulatzai. Chronic Functional Bowel Syndrome Enhances Gut-Brain Axis Dysfunction, Neuroinflammation, Cognitive Impairment, and Vulnerability to Dementia. Neurochemical Research 2014; 39(4): 624 doi: 10.1007/s11064-014-1266-6
|
54 |
Caterina Carco, Wayne Young, Richard B. Gearry, Nicholas J. Talley, Warren C. McNabb, Nicole C. Roy. Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis. Frontiers in Cellular and Infection Microbiology 2020; 10 doi: 10.3389/fcimb.2020.00468
|
55 |
Benjamin I. Brown. Does Irritable Bowel Syndrome Exist? Identifiable and Treatable Causes of Associated Symptoms Suggest It May Not. Gastrointestinal Disorders 2019; 1(3): 314 doi: 10.3390/gidisord1030027
|
56 |
Bruno K. Rodiño-Janeiro, María Vicario, Carmen Alonso-Cotoner, Roberto Pascua-García, Javier Santos. A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies. Advances in Therapy 2018; 35(3): 289 doi: 10.1007/s12325-018-0673-5
|
57 |
M. Schmulson, M.V. Bielsa, R. Carmona-Sánchez, A. Hernández, A. López-Colombo, Y. López Vidal, M. Peláez-Luna, J.M. Remes-Troche, J.L. Tamayo, M.A. Valdovinos. Microbiota, infecciones gastrointestinales, inflamación de bajo grado y antibioticoterapia en el síndrome de intestino irritable. Una revisión basada en evidencias. Revista de Gastroenterología de México 2014; 79(2): 96 doi: 10.1016/j.rgmx.2014.01.004
|
58 |
Xiaojun Zhuang, Lishou Xiong, Li Li, Manying Li, Minhu Chen. Alterations of gut microbiota in patients with irritable bowel syndrome: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology 2017; 32(1): 28 doi: 10.1111/jgh.13471
|
59 |
Daotong Li, Pan Wang, Pengpu Wang, Xiaosong Hu, Fang Chen. The gut microbiota: A treasure for human health. Biotechnology Advances 2016; 34(7): 1210 doi: 10.1016/j.biotechadv.2016.08.003
|
60 |
Ruth M Harvie, Alexandra W Chisholm, Jordan E Bisanz, Jeremy P Burton, Peter Herbison, Kim Schultz, Michael Schultz. Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs. World Journal of Gastroenterology 2017; 23(25): 4632-4643 doi: 10.3748/wjg.v23.i25.4632
|
61 |
Giovanni Barbara, Lisa Zecchi, Raffaella Barbaro, Cesare Cremon, Lara Bellacosa, Marco Marcellini, Roberto De Giorgio, Roberto Corinaldesi, Vincenzo Stanghellini. Mucosal Permeability and Immune Activation as Potential Therapeutic Targets of Probiotics in Irritable Bowel Syndrome. Journal of Clinical Gastroenterology 2012; 46: S52 doi: 10.1097/MCG.0b013e318264e918
|
62 |
Andrew H. Moeller, Patrick H. Degnan, Anne E. Pusey, Michael L. Wilson, Beatrice H. Hahn, Howard Ochman. Chimpanzees and humans harbour compositionally similar gut enterotypes. Nature Communications 2012; 3(1) doi: 10.1038/ncomms2159
|
63 |
Andrea Shin, Geoffrey A. Preidis, Robert Shulman, Purna C. Kashyap. The Gut Microbiome in Adult and Pediatric Functional Gastrointestinal Disorders. Clinical Gastroenterology and Hepatology 2019; 17(2): 256 doi: 10.1016/j.cgh.2018.08.054
|
64 |
Patrícia Borges Botelho, Marcus Vinícius Rodrigues Ferreira, Ananda de Mesquita Araújo, Marcela Moraes Mendes, Eduardo Yoshio Nakano. Effect of multispecies probiotic on gut microbiota composition in individuals with intestinal constipation: A double-blind, placebo-controlled randomized trial. Nutrition 2020; 78: 110890 doi: 10.1016/j.nut.2020.110890
|
65 |
Nirit Keren, Uri Gophna. Beneficial Microorganisms in Multicellular Life Forms. 2012; : 211 doi: 10.1007/978-3-642-21680-0_15
|
66 |
Pål Trosvik, Eric Jacques de Muinck. Ecology of bacteria in the human gastrointestinal tract—identification of keystone and foundation taxa. Microbiome 2015; 3(1) doi: 10.1186/s40168-015-0107-4
|
67 |
Ratnakar Shukla, Ujjala Ghoshal, Tapan N. Dhole, Uday C. Ghoshal. Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis. Digestive Diseases and Sciences 2015; 60(10): 2953 doi: 10.1007/s10620-015-3607-y
|
68 |
Eleonora Distrutti, Lorenzo Monaldi, Patrizia Ricci, Stefano Fiorucci. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World Journal of Gastroenterology 2016; 22(7): 2219-2241 doi: 10.3748/wjg.v22.i7.2219
|
69 |
I. W. Fong. The Role of Microbes in Common Non-Infectious Diseases. 2014; : 1 doi: 10.1007/978-1-4939-1670-2_1
|
70 |
Teemu Rinttilä, Anna Lyra, Lotta Krogius-Kurikka, Airi Palva. Real-time PCR analysis of enteric pathogens from fecal samples of irritable bowel syndrome subjects. Gut Pathogens 2011; 3(1) doi: 10.1186/1757-4749-3-6
|
71 |
Ian B Jeffery, Eileen O'Herlihy, Fergus Shanahan, Paul W O' Toole. Microbiome alterations in IBS. Gut 2020; 69(12): 2263 doi: 10.1136/gutjnl-2020-320919
|
72 |
Mei Luo, Xiaojun Zhuang, Zhenyi Tian, Lishou Xiong. Alterations in short-chain fatty acids and serotonin in irritable bowel syndrome: a systematic review and meta-analysis. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-020-01577-5
|
73 |
Cesare Cremon, Giovanni Carini, Roberto De Giorgio, Vincenzo Stanghellini, Roberto Corinaldesi, Giovanni Barbara. Intestinal dysbiosis in irritable bowel syndrome: etiological factor or epiphenomenon?. Expert Review of Molecular Diagnostics 2010; 10(4): 389 doi: 10.1586/erm.10.33
|
74 |
Priti Devi, Aanchal Yadav, Sunita Yadav, Jyoti Soni, Pallawi Kumari, Aakarshan Raina, Rajesh Pandey. Genomic Surveillance and Pandemic Preparedness. 2023; : 151 doi: 10.1016/B978-0-443-18769-8.00005-2
|
75 |
Minyu Song, Won Seo Park, Jayeon Yoo, Jun-Sang Ham. A Review on Bifidobacteria for Human Health. Journal of Milk Science and Biotechnology 2017; 35(2): 73 doi: 10.22424/jmsb.2017.35.2.73
|
76 |
Marika Björklund, Arthur C. Ouwehand, Sofia D. Forssten, Janne Nikkilä, Kirsti Tiihonen, Nina Rautonen, Sampo J. Lahtinen. Gut microbiota of healthy elderly NSAID users is selectively modified with the administration of Lactobacillus acidophilus NCFM and lactitol. AGE 2012; 34(4): 987 doi: 10.1007/s11357-011-9294-5
|
77 |
S. Fine, C.R. Kelly. The Microbiota in Gastrointestinal Pathophysiology. 2017; : 315 doi: 10.1016/B978-0-12-804024-9.00034-3
|
78 |
Giada De Palma, Stephen M Collins, Premysl Bercik. The microbiota-gut-brain axis in functional gastrointestinal disorders. Gut Microbes 2014; 5(3): 419 doi: 10.4161/gmic.29417
|
79 |
Ravi Kant, Pia Rasinkangas, Reetta Satokari, Taija E. Pietilä, Airi Palva.
Genome Sequence of the Butyrate
-
Producing Anaerobic Bacterium Anaerostipes hadrus PEL 85
. Genome Announcements 2015; 3(2) doi: 10.1128/genomeA.00224-15
|
80 |
Yu Peng, Fubin Liu, Yating Qiao, Peng Wang, Bing Ma, Limin Li, Changyu Si, Xixuan Wang, Ming Zhang, Fangfang Song. Association of abnormal bowel health with major chronic diseases and risk of mortality. Annals of Epidemiology 2022; 75: 39 doi: 10.1016/j.annepidem.2022.09.002
|
81 |
Andrew W. DuPont, Herbert L. DuPont. The intestinal microbiota and chronic disorders of the gut. Nature Reviews Gastroenterology & Hepatology 2011; 8(9): 523 doi: 10.1038/nrgastro.2011.133
|
82 |
Tamar Ringel-Kulka, Andrew K. Benson, Ian M. Carroll, Jaehyoung Kim, Ryan M. Legge, Yehuda Ringel. Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating. American Journal of Physiology-Gastrointestinal and Liver Physiology 2016; 310(6): G417 doi: 10.1152/ajpgi.00044.2015
|
83 |
Ulla Hynönen, Pia Rasinkangas, Reetta Satokari, Lars Paulin, Willem M. de Vos, Taija E. Pietilä, Ravi Kant, Airi Palva. Isolation and whole genome sequencing of a Ruminococcus-like bacterium, associated with irritable bowel syndrome. Anaerobe 2016; 39: 60 doi: 10.1016/j.anaerobe.2016.03.001
|
84 |
Anna Lyra, Lotta Krogius-Kurikka, Janne Nikkilä, Erja Malinen, Kajsa Kajander, Kyösti Kurikka, Riitta Korpela, Airi Palva. Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes. BMC Gastroenterology 2010; 10(1) doi: 10.1186/1471-230X-10-110
|
85 |
Ratnakar Shukla, Yasuo Tsuchiya, Anu Behari, Toshikazu Ikoma, Kazutoshi Nakamura, Vinay K. Kapoor. Metagenomic Analysis of Biliary Microbial Flora in Patients with Gallbladder Cancer or Gallstones-Associated Chronic Cholecystitis. Cancer Investigation 2024; 42(6): 478 doi: 10.1080/07357907.2024.2361305
|
86 |
Fang Yang, Jiaqi Wu, Ning-Yuan Ye, Jing Miu, Jing Yan, Li-Na Liu, Bai Ye, Ashok Pandurangan. Association of Fecal Microbiota with Irritable Bowel Syndrome-Diarrhea and Effect of Traditional Chinese Medicine for Its Management. Gastroenterology Research and Practice 2021; 2021: 1 doi: 10.1155/2021/7035557
|
87 |
Johanna Sundin, Lena Öhman, Magnus Simrén. Understanding the Gut Microbiota in Inflammatory and Functional Gastrointestinal Diseases. Psychosomatic Medicine 2017; 79(8): 857 doi: 10.1097/PSY.0000000000000470
|
88 |
Max Schmulson, María Victoria Bielsa, Ramón Carmona-Sánchez, Angélica Hernández, Aurelio López-Colombo, Yolanda López Vidal, Mario Peláez-Luna, José María Remes-Troche, José Luis Tamayo, Miguel Angel Valdovinos. Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome (IBS): an evidence-based review. Revista de Gastroenterología de México (English Edition) 2014; 79(2): 96 doi: 10.1016/j.rgmxen.2014.01.001
|
89 |
Susanne Verbarg, Markus Göker, Carmen Scheuner, Peter Schumann, Erko Stackebrandt. The Prokaryotes. 2014; : 79 doi: 10.1007/978-3-642-30120-9_205
|
90 |
Georgios Konstantis, Stylianos Efstathiou, Chryssa Pourzitaki, Elisavet Kitsikidou, Georgios Germanidis, Michail Chourdakis. Efficacy and safety of probiotics in the treatment of irritable bowel syndrome: A systematic review and meta-analysis of randomised clinical trials using ROME IV criteria. Clinical Nutrition 2023; 42(5): 800 doi: 10.1016/j.clnu.2023.03.019
|
91 |
Tarek Mazzawi. Gut Microbiota Manipulation in Irritable Bowel Syndrome. Microorganisms 2022; 10(7): 1332 doi: 10.3390/microorganisms10071332
|
92 |
Marieke H. Schoemaker, Jeske H. J. Hageman, Dominique ten Haaf, Anita Hartog, Petra A. M. J. Scholtens, Jos Boekhorst, Arjen Nauta, Rolf Bos. Prebiotic Galacto-Oligosaccharides Impact Stool Frequency and Fecal Microbiota in Self-Reported Constipated Adults: A Randomized Clinical Trial. Nutrients 2022; 14(2): 309 doi: 10.3390/nu14020309
|
93 |
Jing Cheng, Airi M. Palva, Willem M. de Vos, Reetta Satokari. Between Pathogenicity and Commensalism. Current Topics in Microbiology and Immunology 2011; 358: 323 doi: 10.1007/82_2011_189
|
94 |
P. Layer, V. Andresen, H. Allescher, S. C. Bischoff, M. Claßen, S. Elsenbruch, M. Freitag, T. Frieling, M. Gebhard, M. Goebel-Stengel, W. Häuser, G. Holtmann, J. Keller, M. E. Kreis, W. Kruis, J. Langhorst, P. Lynen Jansen, A. Madisch, H. Mönnikes, S. Müller-Lissner, B. Niesler, C. Pehl, D. Pohl, M. Raithel, G. Röhrig-Herzog, M. Schemann, S. Schmiedel, J. Schwille-Kiuntke, M. Storr, J. C. Preiß, T. Andus, S. Buderus, U. Ehlert, M. Engel, A. Enninger, W. Fischbach, A. Gillessen, J. Gschossmann, F. Gundling, S. Haag, U. Helwig, S. Hollerbach, M. Karaus, M. Katschinski, H. Krammer, R. Kuhlbusch-Zicklam, H. Matthes, D. Menge, S. Miehlke, M. C. Posovszky, R. Schaefert, A. Schmidt-Choudhury, O. Schwandner, A. Schweinlin, H. Seidl, A. Stengel, J. Tesarz, I. van der Voort, W. Voderholzer, G. von Boyen, J. von Schönfeld, T. Wedel. Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) – Juni 2021 – AWMF-Registriernummer: 021/016. Zeitschrift für Gastroenterologie 2021; 59(12): 1323 doi: 10.1055/a-1591-4794
|
95 |
H. Duboc, D. Rainteau, S. Rajca, L. Humbert, D. Farabos, M. Maubert, V. Grondin, P. Jouet, D. Bouhassira, P. Seksik, H. Sokol, B. Coffin, J. M. Sabaté. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea‐predominant irritable bowel syndrome. Neurogastroenterology & Motility 2012; 24(6): 513 doi: 10.1111/j.1365-2982.2012.01893.x
|
96 |
Adam M. Nelson, Seth T. Walk, Stefan Taube, Mami Taniuchi, Eric R. Houpt, Christiane E. Wobus, Vincent B. Young, Yolanda Sanz. Disruption of the Human Gut Microbiota following Norovirus Infection. PLoS ONE 2012; 7(10): e48224 doi: 10.1371/journal.pone.0048224
|
97 |
Brent J. Gawey, Ruben A. Mars, Purna C. Kashyap. The role of the gut microbiome in disorders of gut–brain interaction. The FEBS Journal 2024; doi: 10.1111/febs.17200
|
98 |
Helena Tlaskalova-Hogenova, Miloslav Kverka, Elena F. Verdu, Jerry M. Wells. Mucosal Immunology. 2015; : 109 doi: 10.1016/B978-0-12-415847-4.00008-2
|
99 |
Changshan Wan, Xiangxu Kong, Yusheng Liao, Qiuyu Chen, Mengshi Chen, Qian Ding, Xiaotong Liu, Weilong Zhong, Chen Xu, Wentian Liu, Bangmao Wang. Bibliometric analysis of the 100 most-cited papers about the role of gut microbiota in irritable bowel syndrome from 2000 to 2021. Clinical and Experimental Medicine 2022; 23(6): 2759 doi: 10.1007/s10238-022-00971-5
|
100 |
Gopanandan Parthasarathy, Jun Chen, Xianfeng Chen, Nicholas Chia, Helen M. O'Connor, Patricia G. Wolf, H. Rex Gaskins, Adil E. Bharucha. Relationship Between Microbiota of the Colonic Mucosa vs Feces and Symptoms, Colonic Transit, and Methane Production in Female Patients With Chronic Constipation. Gastroenterology 2016; 150(2): 367 doi: 10.1053/j.gastro.2015.10.005
|
101 |
Jyotirmaya Behera, Jessica Ison, Suresh C. Tyagi, Neetu Tyagi. The role of gut microbiota in bone homeostasis. Bone 2020; 135: 115317 doi: 10.1016/j.bone.2020.115317
|
102 |
Klaudia Ustianowska, Łukasz Ustianowski, Filip Machaj, Anna Gorący, Jakub Rosik, Bartosz Szostak, Joanna Szostak, Andrzej Pawlik. The Role of the Human Microbiome in the Pathogenesis of Pain. International Journal of Molecular Sciences 2022; 23(21): 13267 doi: 10.3390/ijms232113267
|
103 |
Linda V. Thomas, Theo Ockhuizen. New insights into the impact of the intestinal microbiota on health and disease: a symposium report. British Journal of Nutrition 2012; 107(S1): S1 doi: 10.1017/S0007114511006970
|
104 |
Lotta Krogius-Kurikka, Anna Lyra, Erja Malinen, Johannes Aarnikunnas, Jarno Tuimala, Lars Paulin, Harri Mäkivuokko, Kajsa Kajander, Airi Palva. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterology 2009; 9(1) doi: 10.1186/1471-230X-9-95
|
105 |
Legaki Evangelia, Eleni Anna Karanasou, Maria Gazouli. Gut Microbiome-Related Diseases and Therapies. The Microbiomes of Humans, Animals, Plants, and the Environment 2021; 1: 41 doi: 10.1007/978-3-030-59642-2_3
|
106 |
Ian M Carroll, Young-Hyo Chang, Jiwon Park, R Balfour Sartor, Yehuda Ringel. Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Gut Pathogens 2010; 2(1) doi: 10.1186/1757-4749-2-19
|
107 |
Aldona Dlugosz, Björn Winckler, Elin Lundin, Katherina Zakikhany, Gunnar Sandström, Weimin Ye, Lars Engstrand, Greger Lindberg. No difference in small bowel microbiota between patients with irritable bowel syndrome and healthy controls. Scientific Reports 2015; 5(1) doi: 10.1038/srep08508
|
108 |
Chiara Ferrario, Valentina Taverniti, Christian Milani, Walter Fiore, Monica Laureati, Ivano De Noni, Milda Stuknyte, Bessem Chouaia, Patrizia Riso, Simone Guglielmetti. Modulation of Fecal Clostridiales Bacteria and Butyrate by Probiotic Intervention with Lactobacillus paracasei DG Varies among Healthy Adults. The Journal of Nutrition 2014; 144(11): 1787 doi: 10.3945/jn.114.197723
|
109 |
Stephen M. Collins. A role for the gut microbiota in IBS. Nature Reviews Gastroenterology & Hepatology 2014; 11(8): 497 doi: 10.1038/nrgastro.2014.40
|
110 |
Gabriella C. van Zanten, Lukasz Krych, Henna Röytiö, Sofia Forssten, Sampo J. Lahtinen, Waleed Abu Al-Soud, Søren Sørensen, Birte Svensson, Lene Jespersen, Mogens Jakobsen. SynbioticLactobacillus acidophilusNCFM and cellobiose does not affect human gut bacterial diversity but increases abundance of lactobacilli, bifidobacteria and branched-chain fatty acids: a randomized, double-blinded cross-over trial. FEMS Microbiology Ecology 2014; 90(1): 225 doi: 10.1111/1574-6941.12397
|
111 |
Ying Zhou, Xin Zhao, Minhong Zhang, Jinghai Feng. Gut microbiota dysbiosis exaggerates ammonia-induced tracheal injury Via TLR4 signaling pathway. Ecotoxicology and Environmental Safety 2022; 246: 114206 doi: 10.1016/j.ecoenv.2022.114206
|
112 |
Pei Pei Chong, Voon Kin Chin, Chung Yeng Looi, Won Fen Wong, Priya Madhavan, Voon Chen Yong. The Microbiome and Irritable Bowel Syndrome – A Review on the Pathophysiology, Current Research and Future Therapy. Frontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.01136
|
113 |
I. M. Carroll, T. Ringel‐Kulka, J. P. Siddle, Y. Ringel. Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea‐predominant irritable bowel syndrome. Neurogastroenterology & Motility 2012; 24(6): 521 doi: 10.1111/j.1365-2982.2012.01891.x
|
114 |
Paul J Kennedy, John F Cryan, Timothy G Dinan, Gerard Clarke. Irritable bowel syndrome: A microbiome-gut-brain axis disorder?. World Journal of Gastroenterology 2014; 20(39): 14105-14125 doi: 10.3748/wjg.v20.i39.14105
|
115 |
T. A. Nelson, S. Holmes, A. V. Alekseyenko, M. Shenoy, T. Desantis, C. H. Wu, G. L. Andersen, J. Winston, J. Sonnenburg, P. J. Pasricha, A. Spormann. PhyloChip microarray analysis reveals altered gastrointestinal microbial communities in a rat model of colonic hypersensitivity. Neurogastroenterology & Motility 2011; 23(2): 169 doi: 10.1111/j.1365-2982.2010.01637.x
|
116 |
Lena Öhman, Hans Törnblom, Magnus Simrén. Crosstalk at the mucosal border: importance of the gut microenvironment in IBS. Nature Reviews Gastroenterology & Hepatology 2015; 12(1): 36 doi: 10.1038/nrgastro.2014.200
|
117 |
B. H. Mullish, D. R. Michael, M. Dabcheva, T. S. Webberley, N. Coates, D. A. John, D. Wang, Y. Luo, S. F. Plummer, J. R. Marchesi. A double‐blind, randomized, placebo‐controlled study assessing the impact of probiotic supplementation on the symptoms of irritable bowel syndrome in females. Neurogastroenterology & Motility 2024; 36(4) doi: 10.1111/nmo.14751
|
118 |
Xiangchao Fu, Bo Zeng, Ping Wang, Lihuan Wang, Bin Wen, Ying Li, Hanzhong Liu, Shiqie Bai, Gang Jia. Microbiome of Total Versus Live Bacteria in the Gut of Rex Rabbits. Frontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.00733
|
119 |
Amanda J. MacFarlane, Nathalie A. Behan, Fernando M. G. Matias, Judy Green, Don Caldwell, Stephen P. J. Brooks. Dietary folate does not significantly affect the intestinal microbiome, inflammation or tumorigenesis in azoxymethane–dextran sodium sulphate-treated mice. British Journal of Nutrition 2013; 109(4): 630 doi: 10.1017/S0007114512001857
|
120 |
Andrés Acosta, Michael Camilleri, Andrea Shin, Sara Linker Nord, Jessica O'Neill, Amber V Gray, Alan J Lueke, Leslie J Donato, Duane D Burton, Lawrence A Szarka, Alan R Zinsmeister, Pamela L Golden, Anthony Fodor. Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome. Clinical and Translational Gastroenterology 2016; 7(5): e173 doi: 10.1038/ctg.2016.32
|
121 |
Shaoming Fang, Xuan Chen, Xiaoxing Ye, Liwen Zhou, Shuaishuai Xue, Qianfu Gan. Effects of Gut Microbiome and Short-Chain Fatty Acids (SCFAs) on Finishing Weight of Meat Rabbits. Frontiers in Microbiology 2020; 11 doi: 10.3389/fmicb.2020.01835
|
122 |
V. N. Drozdov, K. I. Arefev, S. Yu. Serebrova, E. V. Shikh. Clinical efficacy of drugs based on probiotic strains of Saccharomyces boulardii. Meditsinskiy sovet = Medical Council 2020; (5): 104 doi: 10.21518/2079-701X-2020-5-104-112
|
123 |
Robyn Nagel, Rebecca J. Traub, Richard J. N. Allcock, Marcella M. S. Kwan, Helle Bielefeldt-Ohmann. Comparison of faecal microbiota in Blastocystis-positive and Blastocystis-negative irritable bowel syndrome patients. Microbiome 2016; 4(1) doi: 10.1186/s40168-016-0191-0
|
124 |
J. König, R.J. Brummer. Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome. Beneficial Microbes 2014; 5(3): 247 doi: 10.3920/BM2013.0033
|
125 |
Vincenzo Stanghellini, Giovanni Barbara, Cesare Cremon, Rosanna Cogliandro, Alexandra Antonucci, Veronica Gabusi, Chiara Frisoni, Roberto De Giorgio, Valentina Grasso, Mauro Serra, Roberto Corinaldesi. RETRACTED ARTICLE: Gut microbiota and related diseases: clinical features. Internal and Emergency Medicine 2010; 5(S1): 57 doi: 10.1007/s11739-010-0451-0
|
126 |
E. S. Klimenko, N. L. Belkova, A. V. Pogodina, L. V. Rychkova, M. A. Darenskaya. Comorbidity of functional bowel disorders and obesity in terms of microbiome. Acta Biomedica Scientifica 2022; 7(5-2): 56 doi: 10.29413/ABS.2022-7.5-2.6
|
127 |
Ni Yang, Teng Ma, Yong Xie, Qiong Li, Yingmeng Li, Longjin Zheng, Yalin Li, Qiuping Xiao, Zhihong Sun, Kexuan Zuo, Lai-Yu Kwok, Nonghua Lu, Wenjun Liu, Heping Zhang. Lactiplantibacillus plantarum P9 for chronic diarrhea in young adults: a large double-blind, randomized, placebo-controlled trial. Nature Communications 2024; 15(1) doi: 10.1038/s41467-024-51094-2
|